These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 9584259
1. Pregnancy in a woman with maple syrup urine disease. Grünewald S, Hinrichs F, Wendel U. J Inherit Metab Dis; 1998 Apr; 21(2):89-94. PubMed ID: 9584259 [Abstract] [Full Text] [Related]
2. Successful pregnancy in maple syrup urine disease: a case report and review of the literature. Grünert SC, Rosenbaum-Fabian S, Schumann A, Schwab KO, Mingirulli N, Spiekerkoetter U. Nutr J; 2018 May 12; 17(1):51. PubMed ID: 29753318 [Abstract] [Full Text] [Related]
3. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation. Wessel AE, Mogensen KM, Rohr F, Erick M, Neilan EG, Chopra S, Levy HL, Gray KJ, Wilkins-Haug L, Berry GT. JPEN J Parenter Enteral Nutr; 2015 Sep 12; 39(7):875-9. PubMed ID: 24618664 [Abstract] [Full Text] [Related]
4. Treatment of the acute crisis in maple syrup urine disease. Nyhan WL, Rice-Kelts M, Klein J, Barshop BA. Arch Pediatr Adolesc Med; 1998 Jun 12; 152(6):593-8. PubMed ID: 9641714 [Abstract] [Full Text] [Related]
5. Plasma amino acid analyses in two cases of maple syrup urine disease. Surarit R, Srisomsap C, Wasant P, Svasti J, Suthatvoravut U, Chokchaichamnankit D, Liammongkolkul S. Southeast Asian J Trop Med Public Health; 1999 Jun 12; 30 Suppl 2():138-9. PubMed ID: 11400750 [Abstract] [Full Text] [Related]
6. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Pediatrics; 2002 Jun 12; 109(6):999-1008. PubMed ID: 12042535 [Abstract] [Full Text] [Related]
7. [Dietary treatment of maple syrup urine diseases]. Guibaud P, de Parscau L, Guffon N, Laval MC. Pediatrie; 1993 Jun 12; 48(10):681-6. PubMed ID: 8015866 [Abstract] [Full Text] [Related]
9. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. Thompson GN, Francis DE, Halliday D. J Pediatr; 1991 Jul 12; 119(1 Pt 1):35-41. PubMed ID: 2066856 [Abstract] [Full Text] [Related]
10. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Hmiel SP, Martin RA, Landt M, Levy FH, Grange DK. Pediatr Crit Care Med; 2004 May 12; 5(3):278-81. PubMed ID: 15115568 [Abstract] [Full Text] [Related]
11. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland. O'Reilly D, Crushell E, Hughes J, Ryan S, Rogers Y, Borovickova I, Mayne P, Riordan M, Awan A, Carson K, Hunter K, Lynch B, Shahwan A, Rüfenacht V, Häberle J, Treacy EP, Monavari AA, Knerr I. J Inherit Metab Dis; 2021 May 12; 44(3):639-655. PubMed ID: 33300147 [Abstract] [Full Text] [Related]
12. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease. Snyderman SE, Goldstein F, Sansaricq C, Norton PM. Pediatr Res; 1984 Sep 12; 18(9):851-3. PubMed ID: 6483508 [Abstract] [Full Text] [Related]
13. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease. McMahon Y, MacDonnell RC. Adv Perit Dial; 1990 Sep 12; 6():31-4. PubMed ID: 1982835 [Abstract] [Full Text] [Related]
14. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U. Pediatr Res; 2001 May 12; 49(5):627-35. PubMed ID: 11328944 [Abstract] [Full Text] [Related]
15. Dermatitis in treated maple syrup urine disease. Koch SE, Packman S, Koch TK, Williams ML. J Am Acad Dermatol; 1993 Feb 12; 28(2 Pt 2):289-92. PubMed ID: 8436640 [Abstract] [Full Text] [Related]
16. Practical methods to estimate whole body leucine oxidation in maple syrup urine disease. Elsas LJ, Ellerine NP, Klein PD. Pediatr Res; 1993 May 12; 33(5):445-51. PubMed ID: 8511017 [Abstract] [Full Text] [Related]
17. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease. Abi-Wardé MT, Roda C, Arnoux JB, Servais A, Habarou F, Brassier A, Pontoizeau C, Barbier V, Bayart M, Leboeuf V, Chadefaux-Vekemans B, Dubois S, Assoun M, Belloche C, Alili JM, Husson MC, Lesage F, Dupic L, Theuil B, Ottolenghi C, de Lonlay P. J Inherit Metab Dis; 2017 Nov 12; 40(6):783-792. PubMed ID: 28905140 [Abstract] [Full Text] [Related]
18. Changes in branched-chain amino acids in an infant with maple syrup urine disease during perioperative pediatric liver transplant: A case report. Saeyup P, Tubjaroen C, Kamolvisit W, Chongsrisawat V, Thaveepunsan W. Paediatr Anaesth; 2024 Apr 12; 34(4):366-370. PubMed ID: 38314877 [Abstract] [Full Text] [Related]
19. Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Heindel W, Kugel H, Wendel U, Roth B, Benz-Bohm G. Pediatr Radiol; 1995 Apr 12; 25(4):296-9. PubMed ID: 7567243 [Abstract] [Full Text] [Related]
20. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria. Parsons HG, Carter RJ, Unrath M, Snyder FF. J Inherit Metab Dis; 1990 Apr 12; 13(2):125-36. PubMed ID: 2116544 [Abstract] [Full Text] [Related] Page: [Next] [New Search]